• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17565 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     NIHR Health Technology Assessment programme A randomised controlled study of the effectiveness of breathing retraining exercises taught by a physiotherapist either by instructional DVD or in face-to-face sessions in the management of asthma in adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lonoctocog alfa (haemophilia A) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma, first-line treatment) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study results from the PROSPECT Study
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (non-small cell lung cancer) - benefit assessment according to §35a Social Code Book V ]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixekizumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES)
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Secukinumab (plaque psoriasis) - benefit assessment according to §35a Social Code Book V (new scientific findings)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - addendum to order A16-69]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elosulfase alfa (mucopolysaccharidosis type IVA) - assessment according to §35a (para. 1, sentence 11) Social Code Book V (new scientific findings)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Palbociclib (breast cancer) - addendum to commission A16-74]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Obeticholic acid (primary biliary cholangitis) – assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ixazomib (multiple myeloma) – assessment according to § 35a (para. 1, sentence 10) Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Procedure for lung volume reduction in severe lung emphysema]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Analysis of clinical studies of medical devices]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Extracorporeal shock wave therapy (ESWT) for heel pain]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas – addendum to commission H16-02C]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Active knee motion devices in the treatment of anterior cruciate ligament ruptures]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for secondary malignant neoplasms of the liver and the intrahepatic bile ducts – addendum to commission H16-02E]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for a DMP "Depression"]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Update of the guideline synopsis for the DMP "rheumatoid arthritis" - rapid report]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ribociclib (breast cancer) - benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Pembrolizumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Support and Assessment for Fall Emergency Referrals (SAFER) 2: a cluster randomised trial and systematic review of clinical effectiveness and cost-effectiveness of new protocols for emergency ambulance paramedics to assess older people following a fall with referral to community-based care when appropriate
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Angiogenesis inhibitors (bevacizumab - ranibizumab) in neovascular glaucoma and corneal neovascularization]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Darunavir-cobicistat-emtricitabine-tenofovir alafenamide (HIV infection) - benefit assessment according to §35a Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Bariatric surgery as treatment for obesity in subjects over 65 years old]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Avelumab (metastatic Merkel cell carcinoma) - benefit assessment according to §35a (1), sentence 11, Social Code Book V]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) Bariatric surgery to treat obesity in individuals under 21 years old
2017     HAYES, Inc. Dorsal root ganglion stimulation for the treatment of complex regional pain syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Usefulness of N-terminal type B natriuretic propeptide in amyloidosis]
2017     HAYES, Inc. Flexitouch system (Tactile Systems Technology Inc.) for lymphedema
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic magnetic resonance imaging in pelvic floor dysfunction]
2017     HAYES, Inc. Glucagon-like peptide-1 receptor agonists for the treatment of obesity in women with polycystic ovary syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Reducing mammaplasty for the treatment of patients with breast hypertrophy and chronic dorsalgia]
2017     HAYES, Inc. iFuse Implant System (SI-Bone Inc.) for sacroiliac joint fusion for treatment of sacroiliac joint dysfunction
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Arterial stiffness measurement for cardiovascular risk classification in high blood pressure patients]
2017     HAYES, Inc. Gore cardioform septal occluder (W.L. Gore & Associates) for closure of atrial septal defects
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intrathecal opioid infusion pump for chronic cancer and non-cancer pain]
2017     HAYES, Inc. Impella 2.5 System (Abiomed Inc.) for cardiac support in patients undergoing high-risk percutaneous coronary intervention
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Nonmydriatic stereoscopic retinal imaging for retinal condition]
2017     HAYES, Inc. Intravenous immunoglobulin for treatment of intractable epilepsy in pediatric patients
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Transbronchial lung cryobiopsy in diffuse interstitial lung disease diagnosis]
2017     HAYES, Inc. Ketamine infusion for treatment-resistant bipolar depression
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cryoablation for the treatment of persistent or symptomatic paroxysmal atrial fibrillation]
2017     HAYES, Inc. Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
2017     Institute for Clinical Effectiveness and Health Policy (IECS) Biofeedback for women with urinary, fecal or combined incontinence
2017     HAYES, Inc. Ocrelizumab (Ocrevus; Genentech Inc.) for primary progressive and relapsing-remitting multiple sclerosis
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Pomalidomide for relapsed and refractory myeloma]
2017     HAYES, Inc. Radiofrequency nerve ablation for treatment of plantar fasciitis
2017     NIHR Public Health Research (PHR) programme Evaluation of the impacts on health of the proposed UK industry levy on sugar sweetened beverages: developing a systems map and data platform, and collection of baseline and early impact data
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Epidermal growth factor (Heberprot-P®) in chronic ulcers]
2017     HAYES, Inc. Raindrop near vision inlay (ReVision Optics Inc.) for presbyopia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Biological agents and tofacitinib in rheumatoid arthritis]
2017     HAYES, Inc. Teduglutide (Gattex; Shire-NPS Pharmaceuticals Inc.) to reduce parenteral support requirements in adults with short bowel syndrome
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Stiripentol for the treatment of severe myoclonic epilepsy in infants (dravet's syndrome)]
2017     HAYES, Inc. Urolift system (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: beta-lactam allergies, assessment of the risk of cross-reactivity with cephalosporins and carbapenems in penicillin-allergic patients]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Cannabinoids in patients with autism spectrum disorders]
2017     HAYES, Inc. Afirma thyroid FNA analysis (Veracyte)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Transanal endoscopic microsurgery (tem) and transanal minimally invasive surgery (tamis) for the treatment of rectal lesions]
2017     HAYES, Inc. AlloSure (CareDx)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity-modulated radiation therapy for breast cancer]
2017     HAYES, Inc. Cologuard (Exact Sciences Corp.)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: chemoembolization for unresectable liver metastases according to the primary origin and chemoperfusion for advanced pancreatic cancer]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Invasive electroencephalography monitoring with depth electrodes in presurgical assessment of patients with refractory epilepsy]
2017     HAYES, Inc. GeneStrat (Biodesix Inc.)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: comparison of cervical cancer screening strategies involving the human papillomavirus screening test (HPV test) or gynecological cytology (Pap test)]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Gadoxetic acid-enhanced magnetic resonance imaging to diagnose focal liver lesions]
2017     HAYES, Inc. OVA1 (ASPiRA Labs)
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge in support of the decision to integrate new endobronchial ultrasound (EBUS) services in Québec hospitals]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intradialytic parenteral nutrition in patients with chronic kidney conditions]
2017     HAYES, Inc. ThyGenX and ThyraMIR (Interpace Diagnostics)
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Whole exome sequencing in patients with undiagnosed neurological diseases]
2017     HAYES, Inc. Comparative effectiveness of bioresorbable vascular scaffold stents versus other drug-eluting stents for the treatment of coronary artery disease
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Guidelines and standards: fibrinolysis in ST-segment elevation acute myocardial infarction]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Posterior tibial nerve stimulation in overactive bladder]
2017     HAYES, Inc. Comparative effectiveness of endovenous radiofrequency ablation versus conventional surgery for symptomatic varicose veins: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal usage guide: cellulitis in adults and children]
2017     NIHR Health Technology Assessment programme Managing diabetes in people with dementia: a realist review
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Diode laser vaporization in benign prostatic hyperplasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic foot ulcers in adults with diabetes mellitus: a review of reviews
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Motorized Intramedullary nails for bone lenghtening in achondroplasia or hypochondropasia]
2017     HAYES, Inc. Comparative effectiveness of skin substitutes for chronic venous leg ulcers in adults: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: maintaining a stockpile of influenza antivirals in preparation for a flu pandemic]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dimethyl fumarate in multiple sclerosis: Comparison among different commercially available trademarks in Argentina]
2017     HAYES, Inc. Comparative effectiveness review of antimicrobial versus conventional sutures
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: update of proton radiation therapy indications in oncology]
2017     NIHR Health Technology Assessment programme Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Dynamic fixation for spine degenerative diseases]
2017     HAYES, Inc. Comparative effectiveness review of endoscopic therapy for gastroesophageal reflux disease
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Autologous lymph node transfer for lymphedema secondary to breast cancer]
2017     HAYES, Inc. Comparative effectiveness review of hyaluronic acid for knee osteoarthritis: a review of reviews
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Fractional exhaled nitric oxide measurement in patients with asthma and chronic cough]
2017     HAYES, Inc. Comparative effectiveness review of minimally invasive total hip arthroplasty